✦ LIBER ✦

Immune response to enzyme replacement therapy in Fabry disease: Impact on clinical outcome?

✍ Scribed by C.E.M. Hollak; G.E. Linthorst

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fabry disease: clinical outcomes of agal

✍ C. Wanner 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Gastrointestinal manifestations of Fabry

✍ Maryam Banikazemi; Thomas Ullman; Robert. J. Desnick 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Fabry disease in children and response t

✍ U Ramaswami; R Parini; G Pintos-Morell; G Kalkum; C Kampmann; M Beck; on behalf 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Clinical benefit of enzyme replacement t

✍ Breunig, F; Weidemann, F; Strotmann, J; Knoll, A; Wanner, C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Raised HDL cholesterol in Fabry disease:

✍ D. J. Cartwright; A. L. Cole; A. J. Cousins; P. J. Lee 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 48 KB

Monitoring the clinical and biochemical

✍ Kevin Mills; Ashok Vellodi; Peter Morris; Donald Cooper; Michael Morris; Elisabe 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 333 KB